Atrium Health Wake Forest Baptist
11
8
9
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy
Role: collaborator
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Role: collaborator
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
Role: collaborator
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Role: collaborator
Comprehensive Care for AYA: Needs Assessment Survey
Role: collaborator
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
Role: collaborator
Percutaneous Nerve Evaluation Trial Time
Role: collaborator
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Role: collaborator
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
Role: collaborator
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
Role: collaborator
The Better, Harder, Faster, Stronger Study
Role: collaborator
All 11 trials loaded